Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Investigator(s):
Isabella Jade Kuo, M.D.;
Organization:
UCI
NCT Number:
Disease Name:
Critical Limb Ischemia
Disease Category:
Trial Phases:
Phase 3
Trial Status:
Recruiting
Trial Contact:
Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp
Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu